$rNVO
Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
$331.94K
$38.58
3
$867.52K
Novo Nordisk A/S Reality Metrics
Metric
Show % of Total
Key Facts
Type
Fees
Fees
Market Data
Active Addresses
Transfer Count
Transfer Volume
Tokens
Primary Market
Investment
Fees
Fees
Service Providers
Custodian
Legal Identifier
Legal & Regulatory
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Segregation
Remote
Insurance
Fees
Fees
Fees
Fees
Fees
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
RWA.xyzAll Rights Reserved